ClinicalTrials.Veeva
Menu

Find clinical trials for Heart Disease in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Heart Diseases
Cardiovascular Diseases
Heart Failure
Coronary Artery Disease
Myocardial Ischemia
Aortic Valve Stenosis
Heart Valve Diseases

Heart Disease trials near Paris, Île-de-France, FRA:

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD (ASCENT ASD)

Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect

Active, not recruiting
Heart Defects, Congenital
Cardiovascular Diseases
Device: reSept ASD Occluder
atHeart Medical

Paris, France and 31 other locations

Purpose of this prospective, randomized, controlled, multi-center study is to evaluate the safety and efficacy of Transcatheter Aortic Valve Implanta...

Active, not recruiting
Heart Valve Diseases
Aortic Valve Stenosis
Procedure: Transcatheter aortic valve replacement
Optimapharm

Paris, France and 48 other locations

double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart f...

Enrolling
Heart Valve Diseases
Cardiovascular Diseases
Other: Guideline Directed Heart Failure Medication
Device: Carillon Mitral Contour System
Cardiac Dimensions

Paris, France and 92 other locations

The primary objective of this study is to characterize the efficacy and safety of dosing regimens used to transition from prior pericarditis therapie...

Enrolling
Heart Diseases
Pericarditis
Drug: KPL-387

Phase 2

Kiniksa Pharmaceuticals International, plc

Paris, France and 43 other locations

Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a stic...

Enrolling
Heart Diseases
Transthyretin Amyloidosis
Drug: Placebo oral tablet
Drug: Acoramidis

Phase 3

Eidos Therapeutics

Le Kremlin-Bicêtre, France and 103 other locations

Locations recently updated

This study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe ...

Active, not recruiting
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Drug: NNC6019-0001

Phase 2

Novo Nordisk
Novo Nordisk

Créteil, France and 37 other locations

The study intends to compare standard ischemic cold static storage (ICSS) of retrieved hearts intended to be transplanted, to non-ischemic h...

Active, not recruiting
Heart Transplantation
Device: XVIVO heart preservation devices
Device: Standard ICSS
XVIVO
XVIVO

Paris, Paris Cedex, France and 14 other locations

Locations recently updated

with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation...

Enrolling
Chronic Kidney Disease
Atherosclerosis Cardiovascular Disease
Drug: Orforglipron
Drug: Placebo

Phase 3

Lilly
Lilly

Paris, France and 559 other locations

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications o...

Active, not recruiting
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Paris, France and 762 other locations

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...

Active, not recruiting
Cardiovascular Disease
Drug: Cagrilintide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Paris, France and 639 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems